Medtronic beats second-quarter estimates on strength in heart devices segment
(Reuters) -Medical device maker Medtronic topped Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its heart disease and diabetes devices, sending its shares up nearly 4% before the bell. Investor expectations for medical device makers have remained high in recent quarters, boosted by robust demand for surgical procedures, …
Medtronic beats second-quarter estimates on strength in heart devices segment Read More »









